Book online and well send a licensed RN to your home, hotel, office, or event in Austin.
In conjunction with this edition of Ground Truths theres a podcast with Daniel Drucker , the physician-scientist credited as one of the co-discovers of glucagon-like peptide (GLP-1) nearly 3 decades ago.(Sorry that youre getting 2 emails from me today!) He helps explain some of the new findings that Ill be going through here
Okudaira, H., Hongo, O., Ogita, T., Haida, M., Yamauchi, N., Miyamoto, T., Serum IgE and IgE antibody levels in patients with bronchial astma, atopic dermatitis, eosinophilic granulomas of the soft tissue (Kimuras disease) and other diseases, Ann
e202402731
DPP4 in diabetes
Retatrutide represents a genuinely promising development in metabolic medicine, but it is essential that patients and clinicians await the outcome of rigorous Phase 3 trials and regulatory review before drawing firm conclusions about its place in therapy